nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—ALB—acquired immunodeficiency syndrome	0.249	1	CbGaD
Fosphenytoin—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0287	0.0497	CbGbCtD
Fosphenytoin—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.027	0.0467	CbGbCtD
Fosphenytoin—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.027	0.0467	CbGbCtD
Fosphenytoin—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0244	0.0422	CbGbCtD
Fosphenytoin—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0205	0.0354	CbGbCtD
Fosphenytoin—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0185	0.032	CbGbCtD
Fosphenytoin—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0185	0.032	CbGbCtD
Fosphenytoin—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0185	0.032	CbGbCtD
Fosphenytoin—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0183	0.0316	CbGbCtD
Fosphenytoin—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0182	0.0314	CbGbCtD
Fosphenytoin—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0174	0.0301	CbGbCtD
Fosphenytoin—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0172	0.0297	CbGbCtD
Fosphenytoin—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0155	0.0268	CbGbCtD
Fosphenytoin—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0155	0.0268	CbGbCtD
Fosphenytoin—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0152	0.0262	CbGbCtD
Fosphenytoin—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0143	0.0247	CbGbCtD
Fosphenytoin—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0143	0.0247	CbGbCtD
Fosphenytoin—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.014	0.0242	CbGbCtD
Fosphenytoin—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.014	0.0242	CbGbCtD
Fosphenytoin—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0135	0.0232	CbGbCtD
Fosphenytoin—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0134	0.0232	CbGbCtD
Fosphenytoin—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.013	0.0225	CbGbCtD
Fosphenytoin—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0129	0.0223	CbGbCtD
Fosphenytoin—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0129	0.0223	CbGbCtD
Fosphenytoin—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0118	0.0203	CbGbCtD
Fosphenytoin—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0118	0.0203	CbGbCtD
Fosphenytoin—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0113	0.0195	CbGbCtD
Fosphenytoin—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0111	0.0193	CbGbCtD
Fosphenytoin—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0108	0.0187	CbGbCtD
Fosphenytoin—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00979	0.0169	CbGbCtD
Fosphenytoin—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00979	0.0169	CbGbCtD
Fosphenytoin—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00938	0.0162	CbGbCtD
Fosphenytoin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00883	0.0153	CbGbCtD
Fosphenytoin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0083	0.0143	CbGbCtD
Fosphenytoin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0083	0.0143	CbGbCtD
Fosphenytoin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00751	0.013	CbGbCtD
Fosphenytoin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00751	0.013	CbGbCtD
Fosphenytoin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00648	0.0112	CbGbCtD
Fosphenytoin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00629	0.0109	CbGbCtD
Fosphenytoin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00569	0.00983	CbGbCtD
Fosphenytoin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00569	0.00983	CbGbCtD
Fosphenytoin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00546	0.00943	CbGbCtD
Fosphenytoin—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000739	0.0756	CbGeAlD
Fosphenytoin—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000645	0.066	CbGeAlD
Fosphenytoin—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000579	0.0592	CbGeAlD
Fosphenytoin—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000573	0.0586	CbGeAlD
Fosphenytoin—SCN5A—digestive system—acquired immunodeficiency syndrome	0.000441	0.0451	CbGeAlD
Fosphenytoin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000437	0.0447	CbGeAlD
Fosphenytoin—SCN5A—blood—acquired immunodeficiency syndrome	0.00042	0.043	CbGeAlD
Fosphenytoin—SCN5A—vagina—acquired immunodeficiency syndrome	0.00039	0.0398	CbGeAlD
Fosphenytoin—SCN5A—nervous system—acquired immunodeficiency syndrome	0.000341	0.0349	CbGeAlD
Fosphenytoin—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.000328	0.0336	CbGeAlD
Fosphenytoin—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000284	0.0291	CbGeAlD
Fosphenytoin—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000278	0.0285	CbGeAlD
Fosphenytoin—CYP2C19—blood—acquired immunodeficiency syndrome	0.000271	0.0277	CbGeAlD
Fosphenytoin—SCN5A—brain—acquired immunodeficiency syndrome	0.000261	0.0267	CbGeAlD
Fosphenytoin—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000251	0.0257	CbGeAlD
Fosphenytoin—CYP2C8—blood—acquired immunodeficiency syndrome	0.000236	0.0242	CbGeAlD
Fosphenytoin—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000225	0.023	CbGeAlD
Fosphenytoin—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000223	0.0228	CbGeAlD
Fosphenytoin—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.00022	0.0225	CbGeAlD
Fosphenytoin—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000219	0.0224	CbGeAlD
Fosphenytoin—CYP2B6—blood—acquired immunodeficiency syndrome	0.000212	0.0217	CbGeAlD
Fosphenytoin—CYP2C9—blood—acquired immunodeficiency syndrome	0.00021	0.0215	CbGeAlD
Fosphenytoin—ALB—brain—acquired immunodeficiency syndrome	0.000209	0.0213	CbGeAlD
Fosphenytoin—ALB—lymph node—acquired immunodeficiency syndrome	0.000202	0.0206	CbGeAlD
Fosphenytoin—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000197	0.0201	CbGeAlD
Fosphenytoin—CYP2B6—lung—acquired immunodeficiency syndrome	0.000186	0.019	CbGeAlD
Fosphenytoin—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000172	0.0176	CbGeAlD
Fosphenytoin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000168	0.0172	CbGeAlD
Fosphenytoin—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000166	0.0169	CbGeAlD
Fosphenytoin—CYP3A4—blood—acquired immunodeficiency syndrome	0.00016	0.0164	CbGeAlD
Fosphenytoin—CYP2C8—brain—acquired immunodeficiency syndrome	0.000147	0.015	CbGeAlD
Fosphenytoin—CYP2B6—brain—acquired immunodeficiency syndrome	0.000132	0.0135	CbGeAlD
Fosphenytoin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00013	0.0133	CbGeAlD
Fosphenytoin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000125	0.0128	CbGeAlD
Fosphenytoin—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000658	CcSEcCtD
Fosphenytoin—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000658	CcSEcCtD
Fosphenytoin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000657	CcSEcCtD
Fosphenytoin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.000657	CcSEcCtD
Fosphenytoin—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000657	CcSEcCtD
Fosphenytoin—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000656	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000654	CcSEcCtD
Fosphenytoin—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000653	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000653	CcSEcCtD
Fosphenytoin—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000652	CcSEcCtD
Fosphenytoin—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000651	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000651	CcSEcCtD
Fosphenytoin—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.00065	CcSEcCtD
Fosphenytoin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000105	0.000648	CcSEcCtD
Fosphenytoin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000105	0.000648	CcSEcCtD
Fosphenytoin—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000648	CcSEcCtD
Fosphenytoin—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000647	CcSEcCtD
Fosphenytoin—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000647	CcSEcCtD
Fosphenytoin—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000646	CcSEcCtD
Fosphenytoin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000644	CcSEcCtD
Fosphenytoin—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000644	CcSEcCtD
Fosphenytoin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000104	0.000642	CcSEcCtD
Fosphenytoin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000642	CcSEcCtD
Fosphenytoin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000642	CcSEcCtD
Fosphenytoin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000104	0.000642	CcSEcCtD
Fosphenytoin—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000639	CcSEcCtD
Fosphenytoin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000104	0.000638	CcSEcCtD
Fosphenytoin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000637	CcSEcCtD
Fosphenytoin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000637	CcSEcCtD
Fosphenytoin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000636	CcSEcCtD
Fosphenytoin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000636	CcSEcCtD
Fosphenytoin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000636	CcSEcCtD
Fosphenytoin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000103	0.000635	CcSEcCtD
Fosphenytoin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000635	CcSEcCtD
Fosphenytoin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000634	CcSEcCtD
Fosphenytoin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000633	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000633	CcSEcCtD
Fosphenytoin—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000632	CcSEcCtD
Fosphenytoin—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000632	CcSEcCtD
Fosphenytoin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000631	CcSEcCtD
Fosphenytoin—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000631	CcSEcCtD
Fosphenytoin—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.00063	CcSEcCtD
Fosphenytoin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000629	CcSEcCtD
Fosphenytoin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000102	0.000628	CcSEcCtD
Fosphenytoin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000102	0.000627	CcSEcCtD
Fosphenytoin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000626	CcSEcCtD
Fosphenytoin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000102	0.000625	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000625	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000624	CcSEcCtD
Fosphenytoin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000623	CcSEcCtD
Fosphenytoin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000623	CcSEcCtD
Fosphenytoin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000622	CcSEcCtD
Fosphenytoin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000621	CcSEcCtD
Fosphenytoin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.00062	CcSEcCtD
Fosphenytoin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.0001	0.000616	CcSEcCtD
Fosphenytoin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000616	CcSEcCtD
Fosphenytoin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000616	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.0001	0.000615	CcSEcCtD
Fosphenytoin—Cough—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000615	CcSEcCtD
Fosphenytoin—Constipation—Indinavir—acquired immunodeficiency syndrome	9.94e-05	0.000611	CcSEcCtD
Fosphenytoin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	9.93e-05	0.000611	CcSEcCtD
Fosphenytoin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	9.93e-05	0.000611	CcSEcCtD
Fosphenytoin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	9.93e-05	0.000611	CcSEcCtD
Fosphenytoin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	9.91e-05	0.00061	CcSEcCtD
Fosphenytoin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.89e-05	0.000609	CcSEcCtD
Fosphenytoin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.88e-05	0.000608	CcSEcCtD
Fosphenytoin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.87e-05	0.000607	CcSEcCtD
Fosphenytoin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.86e-05	0.000607	CcSEcCtD
Fosphenytoin—Malaise—Lamivudine—acquired immunodeficiency syndrome	9.86e-05	0.000606	CcSEcCtD
Fosphenytoin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.84e-05	0.000605	CcSEcCtD
Fosphenytoin—Nausea—Didanosine—acquired immunodeficiency syndrome	9.84e-05	0.000605	CcSEcCtD
Fosphenytoin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	9.82e-05	0.000604	CcSEcCtD
Fosphenytoin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	9.82e-05	0.000604	CcSEcCtD
Fosphenytoin—Syncope—Lamivudine—acquired immunodeficiency syndrome	9.8e-05	0.000603	CcSEcCtD
Fosphenytoin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	9.8e-05	0.000603	CcSEcCtD
Fosphenytoin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	9.79e-05	0.000602	CcSEcCtD
Fosphenytoin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	9.78e-05	0.000602	CcSEcCtD
Fosphenytoin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	9.76e-05	0.000601	CcSEcCtD
Fosphenytoin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.76e-05	0.0006	CcSEcCtD
Fosphenytoin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.76e-05	0.0006	CcSEcCtD
Fosphenytoin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.69e-05	0.000596	CcSEcCtD
Fosphenytoin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	9.67e-05	0.000595	CcSEcCtD
Fosphenytoin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.64e-05	0.000593	CcSEcCtD
Fosphenytoin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.000591	CcSEcCtD
Fosphenytoin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.58e-05	0.000589	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.57e-05	0.000589	CcSEcCtD
Fosphenytoin—Shock—Ritonavir—acquired immunodeficiency syndrome	9.56e-05	0.000588	CcSEcCtD
Fosphenytoin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.55e-05	0.000587	CcSEcCtD
Fosphenytoin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	9.54e-05	0.000587	CcSEcCtD
Fosphenytoin—Cough—Lamivudine—acquired immunodeficiency syndrome	9.54e-05	0.000587	CcSEcCtD
Fosphenytoin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.54e-05	0.000587	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.51e-05	0.000585	CcSEcCtD
Fosphenytoin—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.51e-05	0.000585	CcSEcCtD
Fosphenytoin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	9.5e-05	0.000585	CcSEcCtD
Fosphenytoin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	9.48e-05	0.000583	CcSEcCtD
Fosphenytoin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	9.47e-05	0.000583	CcSEcCtD
Fosphenytoin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.47e-05	0.000582	CcSEcCtD
Fosphenytoin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.43e-05	0.00058	CcSEcCtD
Fosphenytoin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	9.43e-05	0.00058	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	9.39e-05	0.000578	CcSEcCtD
Fosphenytoin—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.39e-05	0.000578	CcSEcCtD
Fosphenytoin—Rash—Nevirapine—acquired immunodeficiency syndrome	9.39e-05	0.000578	CcSEcCtD
Fosphenytoin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.38e-05	0.000577	CcSEcCtD
Fosphenytoin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	9.37e-05	0.000576	CcSEcCtD
Fosphenytoin—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.37e-05	0.000576	CcSEcCtD
Fosphenytoin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	9.34e-05	0.000575	CcSEcCtD
Fosphenytoin—Headache—Nevirapine—acquired immunodeficiency syndrome	9.33e-05	0.000574	CcSEcCtD
Fosphenytoin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.31e-05	0.000572	CcSEcCtD
Fosphenytoin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9.31e-05	0.000572	CcSEcCtD
Fosphenytoin—Infection—Saquinavir—acquired immunodeficiency syndrome	9.29e-05	0.000572	CcSEcCtD
Fosphenytoin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	9.26e-05	0.00057	CcSEcCtD
Fosphenytoin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	9.25e-05	0.000569	CcSEcCtD
Fosphenytoin—Urticaria—Indinavir—acquired immunodeficiency syndrome	9.23e-05	0.000568	CcSEcCtD
Fosphenytoin—Shock—Saquinavir—acquired immunodeficiency syndrome	9.2e-05	0.000566	CcSEcCtD
Fosphenytoin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.19e-05	0.000566	CcSEcCtD
Fosphenytoin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	9.19e-05	0.000565	CcSEcCtD
Fosphenytoin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.17e-05	0.000564	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.16e-05	0.000563	CcSEcCtD
Fosphenytoin—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.14e-05	0.000562	CcSEcCtD
Fosphenytoin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.13e-05	0.000562	CcSEcCtD
Fosphenytoin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	9.1e-05	0.00056	CcSEcCtD
Fosphenytoin—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.09e-05	0.000559	CcSEcCtD
Fosphenytoin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.09e-05	0.000559	CcSEcCtD
Fosphenytoin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	9.08e-05	0.000558	CcSEcCtD
Fosphenytoin—Rash—Stavudine—acquired immunodeficiency syndrome	9.07e-05	0.000558	CcSEcCtD
Fosphenytoin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.06e-05	0.000557	CcSEcCtD
Fosphenytoin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	9.05e-05	0.000557	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	9.04e-05	0.000556	CcSEcCtD
Fosphenytoin—Headache—Nelfinavir—acquired immunodeficiency syndrome	9.04e-05	0.000556	CcSEcCtD
Fosphenytoin—Headache—Stavudine—acquired immunodeficiency syndrome	9.01e-05	0.000554	CcSEcCtD
Fosphenytoin—Vomiting—Abacavir—acquired immunodeficiency syndrome	9.01e-05	0.000554	CcSEcCtD
Fosphenytoin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	9e-05	0.000553	CcSEcCtD
Fosphenytoin—Constipation—Delavirdine—acquired immunodeficiency syndrome	8.98e-05	0.000553	CcSEcCtD
Fosphenytoin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.97e-05	0.000552	CcSEcCtD
Fosphenytoin—Rash—Abacavir—acquired immunodeficiency syndrome	8.93e-05	0.000549	CcSEcCtD
Fosphenytoin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.92e-05	0.000549	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	8.92e-05	0.000549	CcSEcCtD
Fosphenytoin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.91e-05	0.000548	CcSEcCtD
Fosphenytoin—Headache—Abacavir—acquired immunodeficiency syndrome	8.87e-05	0.000546	CcSEcCtD
Fosphenytoin—Infection—Lamivudine—acquired immunodeficiency syndrome	8.86e-05	0.000545	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.85e-05	0.000545	CcSEcCtD
Fosphenytoin—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.85e-05	0.000544	CcSEcCtD
Fosphenytoin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.84e-05	0.000544	CcSEcCtD
Fosphenytoin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	8.79e-05	0.000541	CcSEcCtD
Fosphenytoin—Shock—Lamivudine—acquired immunodeficiency syndrome	8.78e-05	0.00054	CcSEcCtD
Fosphenytoin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	8.74e-05	0.000538	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.74e-05	0.000537	CcSEcCtD
Fosphenytoin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.72e-05	0.000537	CcSEcCtD
Fosphenytoin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	8.72e-05	0.000537	CcSEcCtD
Fosphenytoin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.68e-05	0.000534	CcSEcCtD
Fosphenytoin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.66e-05	0.000533	CcSEcCtD
Fosphenytoin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.66e-05	0.000533	CcSEcCtD
Fosphenytoin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	8.64e-05	0.000531	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	8.62e-05	0.000531	CcSEcCtD
Fosphenytoin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.57e-05	0.000527	CcSEcCtD
Fosphenytoin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	8.55e-05	0.000526	CcSEcCtD
Fosphenytoin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.55e-05	0.000526	CcSEcCtD
Fosphenytoin—Nausea—Stavudine—acquired immunodeficiency syndrome	8.54e-05	0.000525	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.52e-05	0.000524	CcSEcCtD
Fosphenytoin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.5e-05	0.000523	CcSEcCtD
Fosphenytoin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	8.46e-05	0.00052	CcSEcCtD
Fosphenytoin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.45e-05	0.00052	CcSEcCtD
Fosphenytoin—Nausea—Abacavir—acquired immunodeficiency syndrome	8.41e-05	0.000518	CcSEcCtD
Fosphenytoin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.4e-05	0.000517	CcSEcCtD
Fosphenytoin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.35e-05	0.000513	CcSEcCtD
Fosphenytoin—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.34e-05	0.000513	CcSEcCtD
Fosphenytoin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.34e-05	0.000513	CcSEcCtD
Fosphenytoin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.000513	CcSEcCtD
Fosphenytoin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	8.31e-05	0.000511	CcSEcCtD
Fosphenytoin—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.31e-05	0.000511	CcSEcCtD
Fosphenytoin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.31e-05	0.000511	CcSEcCtD
Fosphenytoin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.26e-05	0.000508	CcSEcCtD
Fosphenytoin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	8.23e-05	0.000506	CcSEcCtD
Fosphenytoin—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.22e-05	0.000506	CcSEcCtD
Fosphenytoin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.13e-05	0.0005	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.13e-05	0.0005	CcSEcCtD
Fosphenytoin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	8.07e-05	0.000496	CcSEcCtD
Fosphenytoin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	8.01e-05	0.000493	CcSEcCtD
Fosphenytoin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	8.01e-05	0.000493	CcSEcCtD
Fosphenytoin—Constipation—Saquinavir—acquired immunodeficiency syndrome	8e-05	0.000492	CcSEcCtD
Fosphenytoin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	7.95e-05	0.000489	CcSEcCtD
Fosphenytoin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.95e-05	0.000489	CcSEcCtD
Fosphenytoin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.95e-05	0.000489	CcSEcCtD
Fosphenytoin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	7.93e-05	0.000488	CcSEcCtD
Fosphenytoin—Rash—Zidovudine—acquired immunodeficiency syndrome	7.88e-05	0.000485	CcSEcCtD
Fosphenytoin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.88e-05	0.000485	CcSEcCtD
Fosphenytoin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.87e-05	0.000484	CcSEcCtD
Fosphenytoin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.85e-05	0.000483	CcSEcCtD
Fosphenytoin—Headache—Zidovudine—acquired immunodeficiency syndrome	7.83e-05	0.000482	CcSEcCtD
Fosphenytoin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.77e-05	0.000478	CcSEcCtD
Fosphenytoin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.76e-05	0.000477	CcSEcCtD
Fosphenytoin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.72e-05	0.000475	CcSEcCtD
Fosphenytoin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.000474	CcSEcCtD
Fosphenytoin—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.69e-05	0.000473	CcSEcCtD
Fosphenytoin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.68e-05	0.000472	CcSEcCtD
Fosphenytoin—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.63e-05	0.000469	CcSEcCtD
Fosphenytoin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.54e-05	0.000464	CcSEcCtD
Fosphenytoin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.51e-05	0.000462	CcSEcCtD
Fosphenytoin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.43e-05	0.000457	CcSEcCtD
Fosphenytoin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.43e-05	0.000457	CcSEcCtD
Fosphenytoin—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.42e-05	0.000457	CcSEcCtD
Fosphenytoin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.39e-05	0.000455	CcSEcCtD
Fosphenytoin—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.39e-05	0.000455	CcSEcCtD
Fosphenytoin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.35e-05	0.000452	CcSEcCtD
Fosphenytoin—Rash—Indinavir—acquired immunodeficiency syndrome	7.33e-05	0.000451	CcSEcCtD
Fosphenytoin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.32e-05	0.00045	CcSEcCtD
Fosphenytoin—Headache—Indinavir—acquired immunodeficiency syndrome	7.28e-05	0.000448	CcSEcCtD
Fosphenytoin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.26e-05	0.000447	CcSEcCtD
Fosphenytoin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.19e-05	0.000442	CcSEcCtD
Fosphenytoin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.09e-05	0.000436	CcSEcCtD
Fosphenytoin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.05e-05	0.000434	CcSEcCtD
Fosphenytoin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.98e-05	0.000429	CcSEcCtD
Fosphenytoin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.97e-05	0.000429	CcSEcCtD
Fosphenytoin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.95e-05	0.000427	CcSEcCtD
Fosphenytoin—Rash—Efavirenz—acquired immunodeficiency syndrome	6.92e-05	0.000426	CcSEcCtD
Fosphenytoin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.92e-05	0.000426	CcSEcCtD
Fosphenytoin—Nausea—Indinavir—acquired immunodeficiency syndrome	6.9e-05	0.000425	CcSEcCtD
Fosphenytoin—Headache—Efavirenz—acquired immunodeficiency syndrome	6.88e-05	0.000423	CcSEcCtD
Fosphenytoin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.87e-05	0.000423	CcSEcCtD
Fosphenytoin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.71e-05	0.000413	CcSEcCtD
Fosphenytoin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.68e-05	0.000411	CcSEcCtD
Fosphenytoin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.65e-05	0.000409	CcSEcCtD
Fosphenytoin—Rash—Delavirdine—acquired immunodeficiency syndrome	6.62e-05	0.000408	CcSEcCtD
Fosphenytoin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.62e-05	0.000407	CcSEcCtD
Fosphenytoin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.62e-05	0.000407	CcSEcCtD
Fosphenytoin—Headache—Delavirdine—acquired immunodeficiency syndrome	6.58e-05	0.000405	CcSEcCtD
Fosphenytoin—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.52e-05	0.000401	CcSEcCtD
Fosphenytoin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.43e-05	0.000395	CcSEcCtD
Fosphenytoin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.4e-05	0.000394	CcSEcCtD
Fosphenytoin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.4e-05	0.000394	CcSEcCtD
Fosphenytoin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.31e-05	0.000388	CcSEcCtD
Fosphenytoin—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.24e-05	0.000384	CcSEcCtD
Fosphenytoin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.18e-05	0.00038	CcSEcCtD
Fosphenytoin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.18e-05	0.00038	CcSEcCtD
Fosphenytoin—Rash—Ritonavir—acquired immunodeficiency syndrome	6.13e-05	0.000377	CcSEcCtD
Fosphenytoin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.12e-05	0.000376	CcSEcCtD
Fosphenytoin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.1e-05	0.000375	CcSEcCtD
Fosphenytoin—Headache—Ritonavir—acquired immunodeficiency syndrome	6.09e-05	0.000374	CcSEcCtD
Fosphenytoin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.95e-05	0.000366	CcSEcCtD
Fosphenytoin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.9e-05	0.000363	CcSEcCtD
Fosphenytoin—Rash—Saquinavir—acquired immunodeficiency syndrome	5.9e-05	0.000363	CcSEcCtD
Fosphenytoin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.89e-05	0.000362	CcSEcCtD
Fosphenytoin—Headache—Saquinavir—acquired immunodeficiency syndrome	5.86e-05	0.00036	CcSEcCtD
Fosphenytoin—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.77e-05	0.000355	CcSEcCtD
Fosphenytoin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.67e-05	0.000349	CcSEcCtD
Fosphenytoin—Rash—Lamivudine—acquired immunodeficiency syndrome	5.63e-05	0.000346	CcSEcCtD
Fosphenytoin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.62e-05	0.000346	CcSEcCtD
Fosphenytoin—Headache—Lamivudine—acquired immunodeficiency syndrome	5.59e-05	0.000344	CcSEcCtD
Fosphenytoin—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.55e-05	0.000342	CcSEcCtD
Fosphenytoin—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.3e-05	0.000326	CcSEcCtD
